C

Clariant AG
XMUN:CLRN

Watchlist Manager
Clariant AG
XMUN:CLRN
Watchlist
Price: 7.79 EUR 1.37% Market Closed
Market Cap: €2.6B

Clariant AG
Investor Relations

Clariant AG is a specialty chemicals company. It makes ingredients and additives that go into products people use every day, such as plastics, coatings, cleaning products, personal care items, and fuels. Instead of selling finished consumer goods, Clariant sells performance chemicals that help manufacturers improve how their own products look, work, or process. Its customers are mainly industrial companies in industries like packaging, construction, automotive, home care, agriculture, and consumer goods. Clariant earns money by selling chemical formulations, catalysts, adsorbents, and other specialty materials, usually through long-term supply relationships and technical support. Many of its products are built around specific customer needs, so the company often works closely with manufacturers to tailor ingredients for a particular production process or end use. What makes Clariant different is that it sits between raw chemical producers and finished-goods makers. It does not compete as a mass commodity chemical supplier; it focuses on higher-value products where formulation know-how, application expertise, and regulatory compliance matter. That makes it an important partner for customers that need reliable chemical inputs rather than standard bulk materials.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
May 8, 2026
AI Summary
Q1 2026

Sales: Clariant reported first-quarter sales of CHF 918 million, down 2% in local currencies, with management saying the result was almost flat after portfolio pruning but hit by a tougher macro backdrop and the Middle East conflict.

Profitability: EBITDA before exceptional items fell 16% to CHF 160 million, with margin down 130 basis points to 17.5% as Catalysts was hit by delayed orders, lower operating leverage and a one-off precious metal sale with no EBITDA contribution.

Middle East impact: The conflict is now the main swing factor for Catalysts, with management saying the quarter saw order delays, force majeure-driven shutdowns and logistics disruptions in both the Middle East and Asia.

Cost pressure: Clariant expects raw materials, energy and logistics inflation to build from Q2 onward, but said it is already pushing through price increases and managing costs actively to offset the pressure.

Guidance unchanged: Full-year 2026 guidance was left unchanged: sales around 2025 levels in local currency, EBITDA margin of up 18% before exceptional items, and free cash flow conversion above 40%.

Savings ahead: The company said its performance improvement program is tracking ahead of plan, with the CHF 80 million run-rate savings now expected by the end of 2026, one year earlier than previously committed.

Key Financials
Sales
CHF 918 million
Underlying sales
almost flat
EBITDA before exceptional items
CHF 160 million
EBITDA margin before exceptional items
17.5%
Cash conversion rate
54%
Pricing
down 1.5%
Volumes
down 0.5%
Currency headwind
7.4%
Care Chemicals sales
down 1.9% in local currency
Care Chemicals EBITDA before exceptional items
CHF 114.6 million
Care Chemicals EBITDA margin
21%
Catalysts sales
down 1.6% in local currency
Catalysts EBITDA before exceptional items
CHF 12.8 million
Catalysts EBITDA margin
9%
Adsorbents and Additives sales
down 2.7% in local currency
Adsorbents and Additives EBITDA before exceptional items
CHF 42.6 million
Adsorbents and Additives EBITDA margin
18.6%
Performance improvement savings
CHF 9 million
Cumulative savings
CHF 59 million
Restructuring charges
CHF 64 million
FTE reduction
around 530 positions
Earnings Call Recording
Other Earnings Calls

Management

Mr. Richard Haldimann Ph.D.
Chief Technology & Sustainability Officer and Head of New Business Development
No Bio Available
Mr. Andreas Schwarzwaelder
Head of Investor Relations
No Bio Available
Dr. Judith Bischoff
General Counsel & Head of Group Legal Services
No Bio Available
Kai Rolker
Head of Group Communications
No Bio Available
Mr. Chris Hansen
Chief Corporate Development Officer
No Bio Available
Ms. Tatiana Berardinelli
Chief Human Resources Officer
No Bio Available
Mr. Joachim Krüger
Head of Corporate Sustainability & Regulatory Affairs
No Bio Available
Monica Ferreira
Region Head of Latin America
No Bio Available
Mr. Christian Vang
President of BU Care Chemicals & Americas Region
No Bio Available
Dr. Stefan Ohren
Head of Product Management High Performance Polycyclic Pigments
No Bio Available

Contacts

Address
BASEL-LANDSCHAFT
Muttenz
Rothausstrasse 61
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett